Tbx2 Directly Represses the Expression of the p21WAF1 Cyclin-Dependent Kinase Inhibitor

Cancer Research

Volumn 64, Issue 5, 2004, Pages 1669-1674

  Prince, Sharon ^a,b   Carreira, Suzanne ^a   Vance, Keith W ^a   Abrahams, Amaal ^b   Goding, Colin R ^a  

^a MARIE CURIE RESEARCH INSTITUTE   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; DNA; PROTEIN P21; RNA; T BOX TRANSCRIPTION FACTOR; T BOX TRANSCRIPTION FACTOR 2; T BOX TRANSCRIPTION FACTOR 3; UNCLASSIFIED DRUG; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; REPRESSOR PROTEIN; T BOX DOMAIN PROTEIN 2; T-BOX DOMAIN PROTEIN 2;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL TRANSFORMATION; CHROMATIN; CONTROLLED STUDY; DNA BINDING; DNA DAMAGE; DNA TRANSFECTION; GENE MUTATION; IMMUNOPRECIPITATION; NONHUMAN; ONCOGENE MYC; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE; ANIMAL; CELL STRAIN COS1; GENE EXPRESSION REGULATION; GENETICS; PHYSIOLOGY; PROMOTER REGION;

ANIMALS; COS CELLS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; GENE EXPRESSION REGULATION; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; T-BOX DOMAIN PROTEINS;

EID: 1642396456     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3286     Document Type: Article

References (51)

1. Papaioannou, V. E., and Silver, L. M. The T-box gene family. BioEssays, 20: 9-19, 1998.
2. Bollag, R. J., Siegried, Z., Cebra-Thomas, J. A., Garvay, N., Davison, E. M., and Silver, L. M. An ancient family of embryonically expressed mouse genes sharing a conserved protein motif with the T-locus. Nat. Genet., 7: 383-389, 1994.
3. Packham, E. A., and Brook, J. D. T-box genes in human disorders. Hum. Mol. Genet., 12: R37-R44, 2003.
4. Merscher, S., Funke, B., Epstein, J. A., Heyer, J., Puech, A., Lu, M. M., Xavier, R. J., Demay, M. B., Russell, R. G., Factor, S., etal. TBX1 is responsible for cardiovascular defects in velo-cardio- facial/DiGeorge syndrome. Cell, 104: 619-629, 2001.
5. Lindsay, E. A., Vitelli, F., Su, H., Morishima, M., Huynh, T., Pramparo, T., Jurecic, V., Ogunrinu, G., Sutherland, H. F., Scambler, P. J., et al. Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature (Lond.), 410: 97-101, 2001.
6. Jerome, L. A., and Papaioannou, V. E. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat. Genet., 27: 286-291, 2001.
7. Basson, C. T., Bachinsky, D. R., Lin, R. C., Levi, T., Elkins, J. A., Soults, J., Grayzel, D., Kroumpouzou, E., Traill, T. A., Leblanc-Straceski, J., et al. Mutations in human TBX5 cause limb and cardiac malformation in Holt-Oram syndrome. Nat. Genet., 15: 30-35, 1997.
8. Naiche, L. A., and Papaioannou, V. E. Loss of Tbx4 blocks hindlimb development and affects vascularization and fusion of the allantois. Development, 130: 2681-2693, 2003.
9. Rallis, C., Bruneau, B. G., Del Buono, J., Seidman, C. E., Seidman, J. G., Nissim, S., Tabin, C. J., and Logan, M. P. Tbx5 is required for forelimb bud formation and continued outgrowth. Development, 130: 2741-2751, 2003.
10. Rodriguez-Esteban, C., Tsukui, T., Yonei, S., Magallon, J., Tamura, K., and Izpisua Belmonte, J. C. The T-box genes Tbx4 and Tbx5 regulate limb outgrowth and identity. Nature (Lond.), 398: 814-818, 1999.
11. Takeuchi, J. K., Koshiba-Takeuchi, K., Matsumoto, K., Vogel-Hopker, A., Naitoh-Matsuo, M., Ogura, K., Takahashi, N., Yasuda, K., and Ogura, T. Tbx5 and Tbx4 genes determine the wing/leg identity of limb buds. Nature (Lond.), 398: 810-814, 1999.
12. Pulichino, A. M., Vallette-Kasic, S., Tsai, J. P., Couture, C., Gauthier, Y., and Drouin, J. Tpit determines alternate fates during pituitary cell differentiation. Genes Dev., 17: 738-747, 2003.
13. Davenport, T. G., Jerome-Majewska, L. A., and Papaioannou, V. E. Mammary gland, limb and yolk sac defects in mice lacking Tbx3, the gene mutated in human ulnar mammary syndrome. Development, 130: 2263-2273, 2003.
14. Bamshad, M., Lin, R. C., Law, D. J., Watkins, W. C., Krakowiak, P. A., Moore, M. E., Franceschini, P., Lala, R., Holmes, L. B., Gebuhr, T. C., et al. Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome. Nat. Genet., 16: 311-315, 1997.
15. Carlson, H., Ota, S., Song, Y., Chen, Y., and Hurlin, P. J. Tbx3 impinges on the p53 pathway to suppress apoptosis, facilitate cell transformation and block myogenic differentiation. Oncogene, 21: 3827-3835, 2002.
16. Carreira, S., Dexter, T. J., Yavuzer, U., Easty, D. J., and Goding, C. R. Brachyury-related transcription factor Tbx2 and repression of the melanocyte-specific TRP-1 promoter. Mol. Cell Biol., 18: 5099-5108, 1998.
17. Carlson, H., Ota, S., Campbell, C. E., and Hurlin, P. J. A dominant repression domain in Tbx3 mediates transcriptional repression and cell immortalization: relevance to mutations in Tbx3 that cause ulnar-mammary syndrome. Hum. Mol. Genet., 10: 2403-2413, 2001.
18. He, M., Wen, L., Campbell, C. E., Wu, J. Y., and Rao, Y. Transcription repression by Xenopus ET and its human ortholog TBX3, a gene involved in ulnar-mammary syndrome. Proc. Natl. Acad. Sci. USA, 96: 10212-10217, 1999.
19. Sinha, S., Abraham, S., Gronostajski, R. M., and Campbell, C. E. Differential DNA binding and transcription modulation by three T-box proteins. T, TBX1 and TBX2. Gene, 258: 15-29, 2000.
20. Brummelkamp, T. R., Kortlever, R. M., Lingbeek, M., Trettel, F., MacDonald, M. E., van Lohuizen, M., and Bernards, R. TBX-3, the gene mutated in ulnar-mammary syndrome, is a negative regulator of p19ARF and inhibits senescence. J. Biol. Chem., 277: 6567-6572, 2002.
21. Jacobs, J. J., Keblusek, P., Robanus-Maandag, E., Kristel, P., Lingbeek, M., Nederlof, P. M., van Welsem, T., van De Vijver, M. J., Koh, E. Y., Daley, G. Q., and van Lohuizen, M. Senescence bypass screen identifies TBX2, which represses cdkn2a (p19ARF) and is amplified in a subset of human breast cancers. Nat. Genet., 26: 291-299, 2000.
22. Lingbeek, M. E., Jacobs, J. J., and van Lohuizen, M. The T-box repressors TBX2 and TBX3 specifically regulate the tumor suppressor gene p14ARF via a variant T-site in the initiator. J. Biol. Chem., 277: 26120-26127, 2002.
23. Sinclair, C. S., Adem, C., Naderi, A., Soderberg, C. L., Johnson, M., Wu, K., Wadum, L., Couch, V. L., Sellers, T. A., Schaid, D., et al. TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors. Cancer Res., 62: 3587-3591, 2002.
24. Gartel, A. L., Serfas, M. S., and Tyner, A. L. p21-negative regulator of the cell cycle. Proc. Soc. Exp. Biol. Med., 213: 138-149, 1996.
25. Bendjennat, M., Boulaire, J., Jascur, T., Brickner, H., Barbier, V., Sarasin, A., Fotedar, A., and Fotedar, R. UV irradiation triggers ubiquitin-dependent degradation of p21WAF1 to promote DNA repair. Cell, 114: 599-610, 2003.
26. el Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
27. Brugarolas, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T., and Hannon, G. J. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature (Lond.), 377: 552-557, 1995.
28. Deng, C., Zhang, P., Harper, J. W., Elledge, S. J., and Leder, P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell, 82: 675-684, 1995.
29. Waldman, T., Kinzler, K. W., and Vogelstein, B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res., 55: 5187-5190, 1995.
30. Waldman, T., Lengauer, C., Kinzler, K. W., and Vogelstein, B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature (Lond.), 381: 713-716, 1996.
31. Adnane, J., Jackson, R. J., Nicosia, S. V., Cantor, A. B., Pledger, W. J., and Sebti, S. M. Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model. Oncogene, 19: 5338-5347, 2000.
32. Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., and Barrett, J. C. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. USA, 93: 13742-13747, 1996.
33. Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., and Smith, J. R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res., 211: 90-98, 1994.
34. Tahara, H., Sato, E., Noda, A., and Ide, T. Increase in expression level of p21sdi1/cip1/waf1 with increasing division age in both normal and SV40-transformed human fibroblasts. Oncogene, 10: 835-840, 1995.
35. Pantoja, C., and Serrano, M. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras. Oncogene, 18: 4974-4982, 1999.
36. Waf1/Cip1. Nature (Lond.), 394: 295-299, 1998.
37. Brown, J. P., Wei, W., and Sedivy, J. M. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science (Wash. DC), 277: 831-834, 1997.
38. Fang, L., Igarashi, M., Leung, J., Sugrue, M. M., Lee, S. W., and Aaronson, S. A. p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53. Oncogene, 18: 2789-2797, 1999.
39. Wang, Y., Blandino, G., and Givol, D. Induced p21waf expression in H1299 cell line promotes cell senescence and protects against cytotoxic effect of radiation and doxorubicin. Oncogene, 18: 2643-2649, 1999.
40. Trettel, F., Rigamonti, D., Hilditch-Maguire, P., Wheeler, V. C., Sharp, A. H., Persichetti, F., Cattaneo, E., and MacDonald, M. E. Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum. Mol. Genet., 9: 2799-2809, 2000.
41. Braunstein, M., Rose, A. B., Holmes, S. G., Allis, C. D., and Broach, J. R. Transcriptional silencing in yeast is associated with reduced nucleosome acetylation. Genes Dev., 7: 592-604, 1993.
42. Stott, F. J., Bates, S., James, M. C., McConnell, B. B., Starborg, M., Brookes, S., Palmero, I., Ryan, K., Hara, E., Vousden, K. H., and Peters, G. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop With p53 and MDM2. EMBO J., 17: 5001-5014, 1998.
43. Pomerantz, J., Schreiber-Agus, N., Liegeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H. W., et al. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell, 92: 713-723, 1998.
44. Kispert, A., Koschorz, B., and Herrmann, B. G. The T protein encoded by Brachyury is a tissue-specific transcription factor. EMBO J., 14: 4763-4772, 1995.
45. Kispert, A., and Herrmann, B. G. The Brachyury gene encodes a novel DNA-binding protein. EMBO J., 12: 3211-3220, 1993.
46. Paxton, C., Zhao, H., Chin, Y., Langner, K., and Reecy, J. Murine Tbx2 contains domains that activate and repress gene transcription. Gene, 283: 117-124, 2002.
47. Conlon, F. L., Fairclough, L., Price, B. M., Casey, E. S., and Smith, J. C. Determinants of T box protein specificity. Development, 128: 3749-3758, 2001
48. Hiroi, Y., Kudoh, S., Monzen, K., Ikeda, Y., Yazaki, Y., Nagai, R., and Komuro, I. Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation. Nat. Genet., 28: 276-280, 2001.
49. Habets, P. E., Moorman, A. F., Clout, D. E., Van Roon, M. A., Lingbeek, M., Van Lohuizen, M., Campione, M., and Christoffels, V. M. Cooperative action of Tbx2 and Nkx2.5 inhibits ANF expression in the atrioventricular canal: implications for cardiac chamber formation. Genes Dev., 16: 1234-1246, 2002.
50. Lamolet, B., Pulichino, A. M., Lamonerie, T., Gauthier, Y., Brue, T., Enjalbert, A., and Drouin, J. A pituitary cell-restricted T box factor. Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell, 104: 849-859, 2001.
51. Tada, M., and Smith, J. C. T-targets: clues to understanding the functions of T-box proteins. Dev. Growth. Differ., 43: 1-11, 2001.